-
Mashup Score: 12HDL cholesterol levels and susceptibility to COVID-19 - 2 year(s) ago
Higher antecedent serum HDL-C, but not LDL-C, TC, or TG, levels were associated with a lower SARS-CoV-2 infection risk. Serum HDL-C, and LDL-C levels declined transiently at the time of infection. Further studies are needed to determine the potential role of lipid-modulating therapies in the prevention and management of COVID-19.
Source: EBioMedicineCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0Single-Cell Analysis Reveals the Range of Transcriptional States of Circulating Human Neutrophils - 2 year(s) ago
This article is featured in Top Reads , p.[][1] [1]: /lookup/volpage/209/643
Source: The Journal of ImmunologyCategories: Allergy-Immunology, Latest HeadlinesTweet-
#JI_TopRead #AuthorChoice from Mariana Kaplan and Luis Franco @NIH @NIH_NIAMS | #SingleCell analysis reveals the range of transcriptional states of circulating human #neutrophils | https://t.co/sRTF2IEes0 #ReadTheJI #immunology #RNAsequencing #OpenAcess #FreetoRead https://t.co/yHYZS0yV4b
-
-
Mashup Score: 14Tumor-Informed Versus Plasma-Only Liquid Biopsy Assay in a Patient With Multiple Primary Malignancies - 2 year(s) ago
In patients with resected colorectal cancer, minimal or molecular residual disease (MRD) assays are now available either commercially or through expanded access programs/clinical trials.1 They can be broadly divided into two types of liquid biopsies.2 First came the tumor-informed circulating tumor DNA (ctDNA)–based platforms in 2019 in the United States (Signatera).3,4 Recently, in 2021,…
Source: JCO Precision OncologyCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @pashtoonkasi: #GI22 @ASCO🗞 Adding to the #ctDNA📂 Hot off the press 🆕@JCOPO_ASCO #OpenAcess 📝 https://t.co/YxzjLLILon Tumor-Informed…
-
-
Mashup Score: 0General Instructions - 2 year(s) ago
About the journal Editorial Policies Data Policy Submission Manuscript preparation Production About the Journal Oxford Open Neuroscience is a fully open
Source: Oxford AcademicCategories: General Medicine News, Latest HeadlinesTweet-
Submit a paper and join the diverse community behind OUP’s new #OpenAcess journal, Oxford Open Neuroscience. Our team of Senior Editors represent the many areas of #neuroscience and are looking for work across the subject. Find out more here: https://t.co/jva6yX8OnY https://t.co/Im0lUiAQfA
-
-
Mashup Score: 0General Instructions - 2 year(s) ago
About the Journal Oxford Open Immunology is a fully open access peer-reviewed journal. All papers published in Oxford Open Immunology are made f
Source: Oxford AcademicCategories: General Medicine News, Latest HeadlinesTweet-
#ECCMID2022 attendees, submit your next paper #OpenAcess to Oxford Open Immunology and enjoy a quick editorial process, with your accepted manuscript online within a week. Visit our Author Guidelines page to learn more. @Daltmann10 https://t.co/4VMxk83C4s https://t.co/5kIh5NIImW
-
-
Mashup Score: 0The use of 3D-printed models in patient communication: a scoping review | Journal of 3D Printing in Medicine - 2 year(s) ago
3D models have been used as an asset in many clinical applications and a variety of disciplines, and yet the available literature studying the use of 3D models in communication is limited. This scoping review has been conducted to draw conclusions on the current evidence and learn from previous studies, using this knowledge to inform future work. Our search strategy revealed 269 papers, 19 of…
Categories: Future of Medicine, Latest HeadlinesTweet-
Read our recently published #OpenAcess #Review article on the use of 3D-printed models in patient communication. 📚https://t.co/tKzrzmogob📚 https://t.co/2YvjjjtRFz
-
-
Mashup Score: 0A diagnostic platform for rapid, simultaneous quantification of procalcitonin and C-reactive protein in human serum - 2 year(s) ago
A fluorescence reader-based duplex LFA for simultaneous quantification of PCT and CRP was developed and successfully validated with clinical samples. The rapid, portable, and low-cost nature of the platform offers potential for differentiation of bacterial and viral infections in emergency and low-resource settings at the point-of-care.
Source: EBioMedicineCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
3rd highlight of Feb issue: @Elvis_Cao @MehtaRG and colls from @WeillCornell developed a multiplex diagnostic platform for differentiating bacterial from viral infections in emergency and low-resource settings at the point-of-care. Read it #openacess https://t.co/upVpK5ekyF https://t.co/PqRc4hLitX
-
-
Mashup Score: 2
Short-term endocrine therapy for 2 to 3 years might be an alternative for patients who have estrogen receptor-low positive breast cancer instead of the standard 5 years. More extensive studies and tr…
Source: American Cancer Society JournalsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Available #OpenAcess | Short-term #EndocrineTherapy for 2-3 years might be an alternative for patients who have ER-low positive #BreastCancer instead of the standard 5 years of treatment. https://t.co/Mej4P2KG1M #BCSM https://t.co/8EifwXpa44
-
-
Mashup Score: 0Tumor-Informed Versus Plasma-Only Liquid Biopsy Assay in a Patient With Multiple Primary Malignancies - 2 year(s) ago
In patients with resected colorectal cancer, minimal or molecular residual disease (MRD) assays are now available either commercially or through expanded access programs/clinical trials.1 They can be broadly divided into two types of liquid biopsies.2 First came the tumor-informed circulating tumor DNA (ctDNA)–based platforms in 2019 in the United States (Signatera).3,4 Recently, in 2021,…
Source: JCO Precision OncologyCategories: Hem/Oncs, Latest HeadlinesTweet-
Our ✍🏽 @JCOPO_ASCO @ASCO amongst the most read📝. If you haven’t had a chance, here’s the #OpenAcess link: https://t.co/Px2gg5ZLFQ Also #VisualAbstract👇🏾. #LiquidBiopsies #ctDNA🔬🩸 💡Multiple primary malignancies an important consideration in an aging population. @OncoAlert https://t.co/75KfNDBe7W
-
-
Mashup Score: 12Tumor-Informed Versus Plasma-Only Liquid Biopsy Assay in a Patient With Multiple Primary Malignancies - 2 year(s) ago
In patients with resected colorectal cancer, minimal or molecular residual disease (MRD) assays are now available either commercially or through expanded access programs/clinical trials.1 They can be broadly divided into two types of liquid biopsies.2 First came the tumor-informed circulating tumor DNA (ctDNA)–based platforms in 2019 in the United States (Signatera).3,4 Recently, in 2021,…
Source: JCO Precision OncologyCategories: Latest Headlines, Oncologists2Tweet-
RT @pashtoonkasi: #GI22 @ASCO🗞 Adding to the #ctDNA📂 Hot off the press 🆕@JCOPO_ASCO #OpenAcess 📝 https://t.co/YxzjLLILon Tumor-Informed…
-
Editor pick for August @vchidambaram91, @AmudhaKumar5 and coll from @uamshealth found that higher serum HDL-C and lower LDL-C levels were associated with reduced risk of #SARSCoV2 infection #COVID19 Read #openacess https://t.co/G7S5c08kZR https://t.co/QWVXiTa0w2